282 related articles for article (PubMed ID: 29702278)
1. Asiatic acid attenuates CCl
Wei L; Chen Q; Guo A; Fan J; Wang R; Zhang H
Int Immunopharmacol; 2018 Jul; 60():1-8. PubMed ID: 29702278
[TBL] [Abstract][Full Text] [Related]
2. Salvianolic acid A attenuates CCl
Wang R; Song F; Li S; Wu B; Gu Y; Yuan Y
Drug Des Devel Ther; 2019; 13():1889-1900. PubMed ID: 31213776
[No Abstract] [Full Text] [Related]
3. Taxifolin, Extracted from Waste
Liu X; Liu W; Ding C; Zhao Y; Chen X; Ling D; Zheng Y; Cheng Z
Drug Des Devel Ther; 2021; 15():871-887. PubMed ID: 33664566
[TBL] [Abstract][Full Text] [Related]
4. The Therapeutic Mechanisms of Propolis Against CCl
Badr G; Sayed EA; Waly H; Hassan KA; Mahmoud MH; Selamoglu Z
Cell Physiol Biochem; 2019; 53(2):301-322. PubMed ID: 31343125
[TBL] [Abstract][Full Text] [Related]
5. Inhibitory effects of octreotide on the progression of hepatic fibrosis via the regulation of Bcl-2/Bax and PI3K/AKT signaling pathways.
Zhang C; An R; Bao YW; Meng XM; Wang TQ; Sun HN; Pan FM; Zhang C
Int Immunopharmacol; 2019 Aug; 73():515-526. PubMed ID: 31173973
[TBL] [Abstract][Full Text] [Related]
6. Antifibrotic effects of tanshinol in experimental hepatic fibrosis by targeting PI3K/AKT/mTOR/p70S6K1 signaling pathways.
Peng R; Wang S; Wang R; Wang Y; Wu Y; Yuan Y
Discov Med; 2017 Feb; 23(125):81-94. PubMed ID: 28371611
[TBL] [Abstract][Full Text] [Related]
7. Asiatic acid ameliorates CCl
Fan J; Chen Q; Wei L; Zhou X; Wang R; Zhang H
Drug Des Devel Ther; 2018; 12():3595-3605. PubMed ID: 30464391
[TBL] [Abstract][Full Text] [Related]
8. Pien-Tze-Huang ameliorates hepatic fibrosis via suppressing NF-κB pathway and promoting HSC apoptosis.
Zheng H; Wang X; Zhang Y; Chen L; Hua L; Xu W
J Ethnopharmacol; 2019 Nov; 244():111856. PubMed ID: 30959141
[TBL] [Abstract][Full Text] [Related]
9. Anti-fibrotic effects of puerarin on CCl4-induced hepatic fibrosis in rats possibly through the regulation of PPAR-γ expression and inhibition of PI3K/Akt pathway.
Guo C; Xu L; He Q; Liang T; Duan X; Li R
Food Chem Toxicol; 2013 Jun; 56():436-42. PubMed ID: 23500774
[TBL] [Abstract][Full Text] [Related]
10. ROS-dependent inhibition of the PI3K/Akt/mTOR signaling is required for Oroxylin A to exert anti-inflammatory activity in liver fibrosis.
Shen M; Guo M; Wang Z; Li Y; Kong D; Shao J; Tan S; Chen A; Zhang F; Zhang Z; Zheng S
Int Immunopharmacol; 2020 Aug; 85():106637. PubMed ID: 32512269
[TBL] [Abstract][Full Text] [Related]
11. Glycyrrhizic acid inhibits apoptosis and fibrosis in carbon-tetrachloride-induced rat liver injury.
Liang B; Guo XL; Jin J; Ma YC; Feng ZQ
World J Gastroenterol; 2015 May; 21(17):5271-80. PubMed ID: 25954100
[TBL] [Abstract][Full Text] [Related]
12. Sini San ameliorates CCl4-induced liver fibrosis in mice by inhibiting AKT-mediated hepatocyte apoptosis.
Jiang M; Huang C; Wu Q; Su Y; Wang X; Xuan Z; Wang Y; Xu F; Ge C
J Ethnopharmacol; 2023 Mar; 303():115965. PubMed ID: 36460296
[TBL] [Abstract][Full Text] [Related]
13. Ginkgo biloba extract mitigates liver fibrosis and apoptosis by regulating p38 MAPK, NF-κB/IκBα, and Bcl-2/Bax signaling.
Wang Y; Wang R; Wang Y; Peng R; Wu Y; Yuan Y
Drug Des Devel Ther; 2015; 9():6303-17. PubMed ID: 26664050
[TBL] [Abstract][Full Text] [Related]
14. Endogenous production of n-3 polyunsaturated fatty acids protects mice from carbon tetrachloride-induced liver fibrosis by regulating mTOR and Bcl-2/Bax signalling pathways.
Shan C; Wang R; Wang S; Zhang Z; Xing C; Feng W; Zhao Z; Zhou S; Zhao AZ; Mu Y; Li F
Exp Physiol; 2021 Apr; 106(4):983-993. PubMed ID: 33605486
[TBL] [Abstract][Full Text] [Related]
15. Yu Gan Long Ameliorates Hepatic Fibrosis by Inhibiting PI3K/AKT, Ras/ERK and JAK1/STAT3 Signaling Pathways in CCl
Li HG; You PT; Xia Y; Cai Y; Tu YJ; Wang MH; Song WC; Quan TM; Ren HY; Liu YW; Dan HX; Xu SQ
Curr Med Sci; 2020 Jun; 40(3):539-547. PubMed ID: 32681257
[TBL] [Abstract][Full Text] [Related]
16. Quercetin prevents hepatic fibrosis by inhibiting hepatic stellate cell activation and reducing autophagy via the TGF-β1/Smads and PI3K/Akt pathways.
Wu L; Zhang Q; Mo W; Feng J; Li S; Li J; Liu T; Xu S; Wang W; Lu X; Yu Q; Chen K; Xia Y; Lu J; Xu L; Zhou Y; Fan X; Guo C
Sci Rep; 2017 Aug; 7(1):9289. PubMed ID: 28839277
[TBL] [Abstract][Full Text] [Related]
17. Inhibitory effects of quercetin on the progression of liver fibrosis through the regulation of NF-кB/IкBα, p38 MAPK, and Bcl-2/Bax signaling.
Wang R; Zhang H; Wang Y; Song F; Yuan Y
Int Immunopharmacol; 2017 Jun; 47():126-133. PubMed ID: 28391159
[TBL] [Abstract][Full Text] [Related]
18. Neurotrophic Effect of Asiatic acid, a Triterpene of Centella asiatica Against Chronic 1-Methyl 4-Phenyl 1, 2, 3, 6-Tetrahydropyridine Hydrochloride/Probenecid Mouse Model of Parkinson's disease: The Role of MAPK, PI3K-Akt-GSK3β and mTOR Signalling Pathways.
Nataraj J; Manivasagam T; Justin Thenmozhi A; Essa MM
Neurochem Res; 2017 May; 42(5):1354-1365. PubMed ID: 28181071
[TBL] [Abstract][Full Text] [Related]
19. Antioxidant and anti-inflammatory activities of berberine attenuate hepatic fibrosis induced by thioacetamide injection in rats.
Eissa LA; Kenawy HI; El-Karef A; Elsherbiny NM; El-Mihi KA
Chem Biol Interact; 2018 Oct; 294():91-100. PubMed ID: 30138605
[TBL] [Abstract][Full Text] [Related]
20. Tetramethylpyrazine attenuates carbon tetrachloride-caused liver injury and fibrogenesis and reduces hepatic angiogenesis in rats.
Zhao S; Zhang Z; Qian L; Lin Q; Zhang C; Shao J; Zhang F; Zheng S
Biomed Pharmacother; 2017 Feb; 86():521-530. PubMed ID: 28024287
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
